Literature DB >> 16081983

Decreased prevalence of virulence factors among ciprofloxacin-resistant uropathogenic Escherichia coli isolates.

S J Drews1, S M Poutanen, T Mazzulli, A J McGeer, A Sarabia, S Pong-Porter, Y Rzayev, B Willey, K Green, D E Low.   

Abstract

Ciprofloxacin resistance was identified in 18% and 6% of consecutively collected, clinically significant urinary tract isolates of Escherichia coli from inpatients and outpatients, respectively. In comparison to ciprofloxacin-susceptible isolates, there were fewer resistant isolates that expressed beta-hemolysis (outpatient, 9% versus 87%, P < 0.0001; inpatient, 4% versus 76%, P < 0.0001) and that had a papEF genotype, genes encoding P fimbriae (outpatient, 30% versus 70%, P = 0.0004; inpatient, 26% versus 70%, P < 0.0001).

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16081983      PMCID： PMC1233890          DOI： 10.1128/JCM.43.8.4218-4220.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  28 in total

1.  The role of bacterial virulence and host factors in patients with Escherichia coli bacteremia who have acute cholangitis or upper urinary tract infection.

Authors:  Ming-Cheng Wang; Chin-Chung Tseng; Chiung-Yu Chen; Jiunn-Jong Wu; Jeng-Jong Huang
Journal:  Clin Infect Dis       Date:  2002-10-28       Impact factor: 9.079

2.  Which fluoroquinolones are suitable for the treatment of urinary tract infections?

Authors:  K G Naber
Journal:  Int J Antimicrob Agents       Date:  2001-04       Impact factor: 5.283

3.  P-fimbriae trigger mucosal responses to Escherichia coli in the human urinary tract.

Authors:  B Wullt; G Bergsten; H Connell; P Röllano; N Gebratsedik; L Hang; C Svanborg
Journal:  Cell Microbiol       Date:  2001-04       Impact factor: 3.715

4.  Are quinolone-resistant uropathogenic Escherichia coli less virulent?

Authors:  Jordi Vila; Karine Simon; Joaquin Ruiz; Juan P Horcajada; Maria Velasco; Margarita Barranco; Antonio Moreno; Josep Mensa
Journal:  J Infect Dis       Date:  2002-09-13       Impact factor: 5.226

5.  Optimal duration of antibiotic therapy for uncomplicated urinary tract infection in older women: a double-blind randomized controlled trial.

Authors:  Thomas Vogel; René Verreault; Marie Gourdeau; Michèle Morin; Lise Grenier-Gosselin; Louis Rochette
Journal:  CMAJ       Date:  2004-02-17       Impact factor: 8.262

6.  PapG-dependent adherence breaks mucosal inertia and triggers the innate host response.

Authors:  Goran Bergsten; Martin Samuelsson; Bjorn Wullt; Irene Leijonhufvud; Hans Fischer; Catharina Svanborg
Journal:  J Infect Dis       Date:  2004-04-14       Impact factor: 5.226

7.  Identification of virulence genes in uropathogenic Escherichia coli by multiplex polymerase chain reaction and their association with infectivity in mice.

Authors:  Michelle D Morin; Walter J Hopkins
Journal:  Urology       Date:  2002-09       Impact factor: 2.649

8.  Evolutionary barriers to quinolone resistance in Streptococcus pneumoniae.

Authors:  Stephen H Gillespie; Leroy L Voelker; Anne Dickens
Journal:  Microb Drug Resist       Date:  2002       Impact factor: 3.431

9.  Structure and antigenic properties of the tip-located P pilus proteins of uropathogenic Escherichia coli.

Authors:  B Lund; F Lindberg; S Normark
Journal:  J Bacteriol       Date:  1988-04       Impact factor: 3.490

10.  Non-hospital antimicrobial usage and resistance in community-acquired Escherichia coli urinary tract infection.

Authors:  G Kahlmeter; P Menday; O Cars
Journal:  J Antimicrob Chemother       Date:  2003-11-12       Impact factor: 5.790
View more
  14 in total

1.  The clinical impact of fluoroquinolone resistance in patients with E coli bacteremia.

Authors:  Bernard C Camins; Jonas Marschall; Shannon R DeVader; Dawn E Maker; Matthew W Hoffman; Victoria J Fraser
Journal:  J Hosp Med       Date:  2011 Jul-Aug       Impact factor: 2.960

2.  Virulence factors in Escherichia coli.

Authors:  James R Johnson
Journal:  J Clin Microbiol       Date:  2005-12       Impact factor: 5.948

3.  Putative link between the virulence-associated fluA gene and fluoroquinolone resistance in uropathogenic Escherichia coli.

Authors:  Petra Lüthje; Annelie Brauner
Journal:  J Clin Microbiol       Date:  2009-12-02       Impact factor: 5.948

4.  Molecular Characterization of Uropathogenic Escherichia coli: Nalidixic Acid and Ciprofloxacin Resistance, Virulent Factors and Phylogenetic Background.

Authors:  Shreya Basu; Sandip Kumar Mukherjee; Avijit Hazra; Mandira Mukherjee
Journal:  J Clin Diagn Res       Date:  2013-12-15

5.  Catheter-associated and nosocomial urinary tract infections: antibiotic resistance and influence on commonly used antimicrobial therapy.

Authors:  Potic B Milan; Ignjatovic M Ivan
Journal:  Int Urol Nephrol       Date:  2008-09-12       Impact factor: 2.370

6.  (CGG)4-based PCR as a novel tool for discrimination of uropathogenic Escherichia coli strains: comparison with enterobacterial repetitive intergenic consensus-PCR.

Authors:  Wioletta Adamus-Bialek; Arkadiusz Wojtasik; Marta Majchrzak; Marek Sosnowski; Pawel Parniewski
Journal:  J Clin Microbiol       Date:  2009-10-21       Impact factor: 5.948

7.  Genetic profiles of fluoroquinolone-resistant Escherichia coli isolates obtained from patients with cystitis: phylogeny, virulence factors, PAIusp subtypes, and mutation patterns.

Authors:  Akira Takahashi; Tetsuro Muratani; Mitsuru Yasuda; Satoshi Takahashi; Koichi Monden; Kiyohito Ishikawa; Hiroshi Kiyota; Soichi Arakawa; Tetsuro Matsumoto; Hiroki Shima; Hisao Kurazono; Shingo Yamamoto
Journal:  J Clin Microbiol       Date:  2009-01-21       Impact factor: 5.948

8.  Virulence factors in urinary Escherichia coli strains: phylogenetic background and quinolone and fluoroquinolone resistance.

Authors:  Gabriella Piatti; Alessandro Mannini; Maria Balistreri; Anna Maria Schito
Journal:  J Clin Microbiol       Date:  2007-12-05       Impact factor: 5.948

9.  Urinary tract infection in a rural community of Nigeria.

Authors:  Bankole Henry Oladeinde; Richard Omoregie; Mitsan Olley; Joshua A Anunibe
Journal:  N Am J Med Sci       Date:  2011-02

10.  Comparative transcription analysis and toxin production of two fluoroquinolone-resistant mutants of Clostridium perfringens.

Authors:  Sunny Park; Miseon Park; Fatemeh Rafii
Journal:  BMC Microbiol       Date:  2013-03-01       Impact factor: 3.605
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.